When used together, a pair of cancer medications can shrink tumors in 60% of patients with advanced-stage melanoma. During an international trial involving 945 patients, UK doctors discovered that ipilimumab and nivolumab can cue the immune system to attack cancerous cells. Unfortunately, the drugs’ side-effects are amplified.

Advertisement

Image: A patient’s CT scan before treatment (left) and 12 weeks after initial treatment. Photograph: Royal Marsden via The Guardian.

Share This Story

Get our newsletter

DISCUSSION

Dr Emilio Lizardo

Let’s play a fun game. Without clicking the link or googling, guess what one year of this therapy costs, retail list price, US Dollars.